RecallDepth
Class I Terminated

Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc., North Wales, PA 19454. NDC 0172-5241-60.

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
May 11, 2022
Posted
June 8, 2022
Recall Number
D-0992-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4224 cartons
Firm Location
Parsippany, NJ, United States

Reason for Recall

Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing.

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Lot # GD01090, Exp 05/2022

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class I Drug recalls